Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/10/1990 | CA1267615A1 Method for recovering purified growth hormones from genetically engineered microorganisms |
04/07/1990 | CA2000263A1 Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells |
04/06/1990 | CA2000309A1 Recombinant pdgf and methods for production |
04/06/1990 | CA2000094A1 H. saimiri-htlv-x region vector |
04/05/1990 | WO1990003576A1 Cell sorting technique and applications thereof |
04/05/1990 | WO1990003446A1 Nucleic acid probes containing improved molecular switch, and assays and kits incorporating same |
04/05/1990 | WO1990003439A1 Method of gene transfer into chickens and other avian species |
04/05/1990 | WO1990003438A1 Improved bacterial strains for heterologous gene expression |
04/05/1990 | WO1990003437A1 Proteins for fusing the sub-unit b of the choleraic toxin and heterologous antigen, and nucleic acids encoding them |
04/05/1990 | WO1990003436A1 tPA-LIKE POLYPEPTIDES, THEIR MANUFACTURE AND USE |
04/05/1990 | WO1990003435A2 Nucleic acid coding for the human angiotensine conversion enzyme (ace), and its applications particularly for the in vitro diagnosis of high blood pressure |
04/05/1990 | WO1990003434A1 Recombinant dna coding for bacillus thuringiensis endotoxin |
04/05/1990 | WO1990003433A1 Vaccine |
04/05/1990 | WO1990003431A1 Mixed feed recombinant yeast fermentation |
04/05/1990 | WO1990003430A1 Cell culture medium for enhanced cell growth, culture longevity and product expression |
04/05/1990 | WO1990003428A1 Process for the multiple oxidation of steroids and genetically engineered cells to be used therefor |
04/05/1990 | WO1990003400A1 Intercellular adhesion molecules, and their binding ligands |
04/05/1990 | WO1990003398A1 Capsular polysaccharide adhesin antigen, preparation, purification and use |
04/05/1990 | WO1990003396A1 Dna damage-binding factor and uses therefor |
04/05/1990 | WO1990003394A2 New limphokines, dna sequences coding for said limphokines and pharmaceutical compositions containing said limphokines |
04/05/1990 | WO1990003388A1 A preparation of plasminogen activator expressed in prokaryonts |
04/05/1990 | WO1990003384A1 Antiviral oligomers |
04/05/1990 | WO1990003177A1 Animal model for diagnosing and testing vaccines or therapeutic agents against aids |
04/05/1990 | WO1989001970A3 Transformed lactic acid bacteria |
04/05/1990 | DE3932461A1 Monoklonaler antikoerper gegen ein synthetisches peptid und verfahren zu dessen herstellung A monoclonal antibody against a synthetic peptide and process for its preparation |
04/05/1990 | CA2000192A1 Solid medium and method for dna storage |
04/04/1990 | EP0362183A2 Process for the production of human lysozyme |
04/04/1990 | EP0362179A2 Recombinant saccharomyces |
04/04/1990 | EP0361991A2 Method for the microbiological preparation of human serum albumin and other heterologous proteins from a yeast |
04/04/1990 | EP0361983A2 RNA template end-linked probe constructs and methods for use |
04/04/1990 | EP0361956A2 Increased expression of small molecular weight recombinant proteins |
04/04/1990 | EP0361905A2 Carbomycin biosynthetic genes, designated carL and carM, for use in streptomyces and other organisms |
04/04/1990 | EP0361749A1 A vector comprising a replication competent HIV-I provirus and a heterologous gene |
04/04/1990 | EP0361475A1 Preparation of a plasminogen activator expressed in procaryotic cells |
04/04/1990 | EP0361284A2 T cell growth factor |
04/04/1990 | EP0361182A1 Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same |
04/04/1990 | EP0360940A2 Polynucleotide determination with selectable cleavage sites |
04/04/1990 | EP0360937A1 Improved process for recovering microbially produced interferonbeta |
04/04/1990 | CN1041005A Post-transfusion, on-a, non-b hepatitis virus and antigens |
04/03/1990 | US4914033 Structure and properties of modified interferons |
04/03/1990 | US4914031 Subtilisin analogs |
04/03/1990 | US4914030 Carbomycin resistance-conferring gene, designated carb, for use in streptomyces and other organisms |
04/03/1990 | US4914027 Process for the microbiological preparation of human serum albumin |
04/03/1990 | US4914026 Yeast culture, proinsulin, gene expression, secretion signals |
04/03/1990 | US4914025 Export of intra-cellular substances |
04/03/1990 | CA2000098A1 Pyruvate oxidase mutants and process for the preparation thereof |
04/03/1990 | CA2000044A1 Monoclonal antibodies against receptor induced binding sites |
04/03/1990 | CA1267497A1 Protein recovery |
04/03/1990 | CA1267496A1 Purification and activation of proteins from insoluble inclusion bodies |
04/03/1990 | CA1267373A1 Process for producing alcohol |
04/03/1990 | CA1267372A1 Glucoamylase gene |
03/28/1990 | EP0360750A2 Novel herbicide tolerant plants |
03/28/1990 | EP0360641A1 DNA sequence participating in the regulation of the expression of a DNA sequence encoding a polypeptide precursor, expression vectors, and method for the periplasmic production of the polypeptide |
03/28/1990 | EP0360568A2 Biocontrol of microbial pathogens |
03/28/1990 | EP0360411A1 O-glycosylated IGF-1 |
03/28/1990 | EP0360361A1 Process for the multiple oxidation of steroids and genetically engineered cells to be used therefor |
03/28/1990 | EP0360257A2 RNA catalyst for cleaving specific RNA sequences |
03/28/1990 | EP0360006A2 Acid-resistant fibroblast growth factor composition for treating ulcerating diseases of the gastrointestinal tract |
03/28/1990 | EP0359998A2 Factor regulating gene expression |
03/28/1990 | EP0359919A2 Recombinant mycoplasma hyopneumoniae antigen and uses therefor |
03/28/1990 | EP0359789A1 Amplification and detection of nucleic acid sequences. |
03/28/1990 | CN1040823A 黄瓜花叶病毒外壳蛋白基因 Cucumber mosaic virus coat protein gene |
03/28/1990 | CN1040822A Process for preparation of motilin-like polypeptide and expression thereof |
03/28/1990 | CN1040741A Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
03/27/1990 | US4912207 Genetic engineering |
03/27/1990 | US4912200 Extraction of granulocyte macrophage colony stimulating factor from bacteria |
03/27/1990 | US4912046 Portable inducible control system |
03/27/1990 | US4912044 Complexing Dna with cloning vector; insertion into microorganism |
03/27/1990 | US4912040 Eucaryotic expression system |
03/27/1990 | US4912039 Multidrug resistance in mammalian cell lines and isolation of determinant glycoprotein DNA |
03/27/1990 | US4912038 Recombinant DNA sequence encoding alveolar surfactant protein |
03/27/1990 | US4911909 Method of controlling hypertension using monoclonal antibodies to angiotensin-II |
03/27/1990 | EP0289597A4 Eucaryotic expression system. |
03/27/1990 | CA1267099A1 Secretion of correctly processed human growth hormone in e.coli and pseudomonas |
03/27/1990 | CA1267098A1 Detection of b-cell neoplasms |
03/22/1990 | WO1990002821A1 Detection of human papillomavirus by the polymerase chain reaction |
03/22/1990 | WO1990002820A1 Replicative rna-based amplification/detection systems |
03/22/1990 | WO1990002815A1 Isolation, purification, and characterization of the aminopeptidases: mas ii and mas iii |
03/22/1990 | WO1990002814A1 Isolation, purification, and characterization of the aminopeptidases: ap2, api, and apx |
03/22/1990 | WO1990002812A1 Methods for producing gonadotropin and tsh super-agonists |
03/22/1990 | WO1990002811A1 A malaria antigen |
03/22/1990 | WO1990002810A1 Production of interleukin-2 polypeptides in pichia pastoris yeast cells |
03/22/1990 | WO1990002809A1 Generation and selection of recombinant varied binding proteins |
03/22/1990 | WO1990002808A2 Fermentation of genetically engineered yeast in the presence of a polyalkylene compound |
03/22/1990 | WO1990002806A1 Recombinant retroviruses with amphotropic and ecotropic host ranges |
03/22/1990 | WO1990002805A1 A process for activating nodulation promoters of rhizobium-bacteria |
03/22/1990 | WO1990002804A1 Stress-tolerant plants |
03/22/1990 | WO1990002803A2 Viral vaccines |
03/22/1990 | WO1990002802A2 Viral nucleotide sequences |
03/22/1990 | WO1990002801A2 Plants transformed with a dna sequence from bacillus thuringiensis lethal to lepidoptera |
03/22/1990 | WO1990002800A1 New derivatives of human/bovine basic fibroblast growth factor |
03/22/1990 | WO1990002798A1 Tissue plasminogen activator having zymogenic or fibrin specific properties |
03/22/1990 | WO1990002797A1 Self-inactivating, replication defective, retroviral vectors and helper cells for producing the same |
03/22/1990 | WO1990002796A1 Three-dimensional cell and tissue culture system |
03/22/1990 | WO1990002762A1 Macrophage-derived inflammatory mediator (mip-2) |
03/22/1990 | WO1990002757A1 Heteropolymeric protein |
03/22/1990 | WO1990002752A1 Allelic variants of plasmodium falciparum merozoite surface antigen |
03/22/1990 | WO1990002569A1 Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
03/22/1990 | WO1990002568A1 Hiv-1 envelope muteins lacking hypervariable domains |
03/22/1990 | WO1990002566A1 Fusion protein of paramyxovirus, method of production using recombinant baculovirus expression vector, vaccine comprising such protein and use thereof |